2.335

0.64% -0.015

Spero Therapeutics Inc (SPRO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.35

Offen:

$2.34

24-Stunden-Volumen:

290.23K

Relative Volume:

0.07

Marktkapitalisierung:

$130.55M

Einnahmen:

$76.19M

Nettoeinkommen (Verlust:

$-1.61M

KGV:

233.50

EPS:

0.01

Netto-Cashflow:

$28.98M

1W Leistung:

-1.48%

1M Leistung:

-19.48%

6M Leistung:

+169.10%

1J Leistung:

+65.02%

1-Tages-Spanne:

$2.32

$2.4025

1-Wochen-Bereich:

$2.30

$2.45

52-Wochen-Spanne:

$0.5052

$3.22

Spero Therapeutics Inc Stock (SPRO) Company Profile

Firmenname

Spero Therapeutics Inc

Sektor

Healthcare (1162)

Branche

Biotechnology (651)

Telefon

857-242-1600

Adresse

675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA

Mitarbeiter

Twitter

@spero_tx

Nächster Verdiensttermin

2025-03-19

Neueste SEC-Einreichungen

SPRO's Discussions on Twitter

Vergleichen Sie SPRO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SPRO Spero Therapeutics Inc	2.335	133.07M	76.19M	-1.61M	28.98M	0.01
VRTX Vertex Pharmaceuticals Inc	469.90	122.48B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	566.75	61.80B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	329.21	42.46B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	592.45	35.22B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	291.75	31.91B	3.81B	-644.79M	-669.77M	-6.24

Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-20	Herabstufung	Evercore ISI	Outperform → In-line
2022-09-23	Hochstufung	Evercore ISI	In-line → Outperform
2021-10-01	Herabstufung	Oppenheimer	Outperform → Perform
2021-01-22	Bestätigt	H.C. Wainwright	Buy
2020-12-16	Eingeleitet	Berenberg	Buy
2020-09-29	Eingeleitet	Evercore ISI	Outperform
2019-11-05	Bestätigt	H.C. Wainwright	Buy
2019-09-09	Eingeleitet	Janney	Buy
2018-02-09	Eingeleitet	Cantor Fitzgerald	Overweight
2017-11-27	Eingeleitet	BofA/Merrill	Neutral
2017-11-27	Eingeleitet	Oppenheimer	Outperform
2017-11-27	Eingeleitet	Stifel	Buy

Alle ansehen

Spero Therapeutics Inc Aktie (SPRO) Neueste Nachrichten

09:10 AM

Is Spero Therapeutics Inc. a good long term investmentExceptional market positioning - PrintWeekIndia

09:10 AM

08:35 AM

What drives Spero Therapeutics Inc. stock priceTriple-digit growth rates - Autocar Professional

08:35 AM

Jul 24, 2025

What analysts say about Spero Therapeutics Inc. stockSuperior portfolio returns - Autocar Professional

Jul 24, 2025

What institutions are buying Spero Therapeutics Inc. stock nowBreakneck growth rates - jammulinksnews.com

Jul 24, 2025

What risks could impact Spero Therapeutics Inc. stock performanceOutstanding stock performance - jammulinksnews.com

Jul 24, 2025

Why Spero Therapeutics Inc. stock is on top investor watchlistsOutstanding capital appreciation - jammulinksnews.com

Jul 24, 2025

Jul 22, 2025

Spero Therapeutics Inc. Stock Analysis and ForecastConsistently superior profits - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

Will Spero Therapeutics Inc. stock benefit from AI tech trendsTrend Based Entry Alerts - Newser

Jul 18, 2025

When is the best time to buy Spero Therapeutics Inc. stockFree Real-Time Trading Opportunities - Newser

Jul 18, 2025

Jul 16, 2025

Insufficient Growth At Spero Therapeutics, Inc. (NASDAQ:SPRO) Hampers Share Price - simplywall.st

Jul 16, 2025

Jul 15, 2025

What makes Spero Therapeutics Inc. stock price move sharplyMarket Timing Advice - Newser

Jul 15, 2025

Why Spero Therapeutics Inc. stock attracts strong analyst attentionTop Momentum Stock Pick - Newser

Jul 15, 2025

How Spero Therapeutics Inc. stock performs during market volatilityBreakout Level Watch - Newser

Jul 15, 2025

Jul 01, 2025

Spero Therapeutics (NASDAQ:SPRO) Stock Passes Above Fifty Day Moving Average – What’s Next? - Defense World

Jul 01, 2025

Jun 28, 2025

While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership - Yahoo

Jun 28, 2025

Jun 25, 2025

Is Spero Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 17, 2025

Complicated Urinary Tract Infection Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 17, 2025

Jun 12, 2025

SPRO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jun 12, 2025

Jun 11, 2025

Spero TherapeuticsAdditional Upside Potential Following Positive Phase 3 Results (SPRO) - Seeking Alpha

Jun 11, 2025

Squarepoint Ops LLC Buys Shares of 55,051 Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 11, 2025

Jun 09, 2025

Spero Therapeutics COO Timothy Keutzer sells shares for $44,097 - MSN

Jun 09, 2025

Jane Street Group LLC Takes Position in Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 09, 2025

Jun 06, 2025